| Product NDC: | 23155-012 |
| Proprietary Name: | PROPOXYPHENE HYDROCHLORIDE |
| Non Proprietary Name: | propoxyphene hydrochloride |
| Active Ingredient(s): | 65 mg/1 & nbsp; propoxyphene hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 23155-012 |
| Labeler Name: | Heritage Pharmaceuticals Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA080530 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090501 |
| Package NDC: | 23155-012-01 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (23155-012-01) |
| NDC Code | 23155-012-01 |
| Proprietary Name | PROPOXYPHENE HYDROCHLORIDE |
| Package Description | 100 CAPSULE in 1 BOTTLE (23155-012-01) |
| Product NDC | 23155-012 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | propoxyphene hydrochloride |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20090501 |
| Marketing Category Name | ANDA |
| Labeler Name | Heritage Pharmaceuticals Inc |
| Substance Name | PROPOXYPHENE HYDROCHLORIDE |
| Strength Number | 65 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |